Furthermore, participants assigned to tirzepatide had a slower mean rate of decline in estimated glomerular filtration rate over the study period: 1.4 0.2 ml/min/1.73 m 2 body mass per year with tirzepatide compared with 3.6 0.2 ml/min/1.73 m 2 body mass per year with insulin glargine, for a between-group difference of 2.2 ml/min/1.73 m 2 body mass per year [95% CI 1.62.8 ml/min/1.73 m 2 body mass per year] [95]
I experienced some side effects, but my body quickly adjusted
Whilst generally well-tolerated, it can cause gastrointestinal side effects (steatorrhoea, faecal urgency) that may be problematic in Crohn's disease
If symptoms persist or worsen despite these measures, patients should seek further medical review as this may indicate an unrelated condition requiring different management
Sealed vials remain stable for extended periods when stored cold and protected from light and moisture
These authors analyzed adverse drug events (ADEs) reports from the 2nd quarter of 2022 to the 4th quarter of 2023 using the reporting odds ratio (ROR) and Bayesian Confidence Propagation Neural Network (BCPNN) methods
